GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

GSK split will help deal with ‘perennial underperformance’, ... Haleon, a joint venture with Pfizer that owns brands including Sensodyne toothpaste and Centrum vitamins, ...